Baxter International Inc at JPMorgan Healthcare Conference Transcript

Jan 10, 2022 / 02:45PM GMT
Robert Justin Marcus - JPMorgan Chase & Co, Research Division - Analyst

Good morning, everyone. Happy to host our next session with Baxter. We have CEO, Joe Almeida. And joining us later for Q&A is CFO, Jay Saccaro. I'm Robbie Marcus, med tech analyst at JPMorgan.

Just a reminder, feel free to submit questions online or e-mail or chat me online. If you have questions, I'll do my best to answer them. Otherwise, Joe, I'll turn it over to you, and I'll see you in a few minutes for Q&A.

Jose E. Almeida - Baxter International Inc. - Chairman of the Board, President & CEO

Thank you, Robbie. Good morning, everyone. I would like to start the meeting today wishing everyone a Happy New Year and wishing you all be healthy and safe. Our safe harbor statement is in the second page of the presentation and extensive, and you should read that carefully.

Baxter is a 90-year company that is well positioned to operate in the current health care space and for the future as well. We have medically necessary products and therapies across the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot